| 言語 |
英語
|
| 著者 |
Murakawa Yohko
Shimane University, Izumo, Japan
|
| 掲載誌名 |
ARTHRITIS & RHEUMATOLOGY
|
| 巻 | 66
|
| 号 | 8
|
| 開始ページ | 2297
|
| 終了ページ | 2307
|
| ISSN | 2326-5191
|
| ISSN（Online） | 2326-5205
|
| 発行日 | 2014-08
|
| DOI | |
| PubMed ID | |
| 出版者 | WILEY
|
| 資料タイプ |
学術雑誌論文
|
| 部局 |
医学部
|
| 備考 | Dr. Kumakura has received speaking fees from Dainippon Sumitomo Pharma (less than $10,000). Dr. Murakawa has received speaking fees from Chugai Pharma, Eisai, Mitsubishi Tanabe Pharma, Pfizer, Astellas Pharma, Takeda Pharma, Janssen Pharma, Santen Pharma, Bristol-Myers Squibb, Ono Pharma, Kissei Pharma, Actelion Pharma, and AbbVie Japan and research grant support from Teijin Pharma, Astellas Pharma, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma, Chugai Pharma, Takeda Pharma, and Eisai (less than $10,000 each).
|
